- Home
- AMWD vs EYPT Comparison
AMWD vs EYPT Comparison
Compare AMWD & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWD
- EYPT
- Stock Information
- Founded
- AMWD 1980
- EYPT 1987
- Country
- AMWD United States
- EYPT United States
- Employees
- AMWD N/A
- EYPT N/A
- Industry
- AMWD Forest Products
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- AMWD Basic Materials
- EYPT Industrials
- Exchange
- AMWD Nasdaq
- EYPT Nasdaq
- Market Cap
- AMWD 940.7M
- EYPT 967.4M
- IPO Year
- AMWD N/A
- EYPT 2005
- Fundamental
- Price
- AMWD $53.85
- EYPT $11.84
- Analyst Decision
- AMWD Buy
- EYPT Strong Buy
- Analyst Count
- AMWD 3
- EYPT 5
- Target Price
- AMWD $70.00
- EYPT $29.60
- AVG Volume (30 Days)
- AMWD 166.5K
- EYPT 1.6M
- Earning Date
- AMWD 11-25-2025
- EYPT 11-05-2025
- Dividend Yield
- AMWD N/A
- EYPT N/A
- EPS Growth
- AMWD N/A
- EYPT N/A
- EPS
- AMWD 5.62
- EYPT N/A
- Revenue
- AMWD $1,653,503,000.00
- EYPT $42,339,000.00
- Revenue This Year
- AMWD N/A
- EYPT N/A
- Revenue Next Year
- AMWD $3.80
- EYPT N/A
- P/E Ratio
- AMWD $9.62
- EYPT N/A
- Revenue Growth
- AMWD N/A
- EYPT N/A
- 52 Week Low
- AMWD $50.00
- EYPT $3.91
- 52 Week High
- AMWD $104.28
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- AMWD 27.85
- EYPT 47.55
- Support Level
- AMWD $54.11
- EYPT $10.28
- Resistance Level
- AMWD $57.45
- EYPT $13.32
- Average True Range (ATR)
- AMWD 2.58
- EYPT 0.89
- MACD
- AMWD -1.07
- EYPT -0.02
- Stochastic Oscillator
- AMWD 3.79
- EYPT 59.26
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.